List of Excipients in API lorcaserin hydrochloride hemihydrate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lorcaserin hydrochloride hemihydrate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eisai Inc | BELVIQ | lorcaserin hydrochloride hemihydrate | 62856-529 | CELLULOSE, MICROCRYSTALLINE | 2029-04-18 |
| Eisai Inc | BELVIQ | lorcaserin hydrochloride hemihydrate | 62856-529 | CROSCARMELLOSE SODIUM | 2029-04-18 |
| Eisai Inc | BELVIQ | lorcaserin hydrochloride hemihydrate | 62856-529 | FD&C BLUE NO. 2 | 2029-04-18 |
| Eisai Inc | BELVIQ | lorcaserin hydrochloride hemihydrate | 62856-529 | HYDROXYPROPYL CELLULOSE | 2029-04-18 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for lorcaserin hydrochloride hemihydrate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
lorcaserin hydrochloride hemihydrate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
lorcaserin hydrochloride hemihydrate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
lorcaserin hydrochloride hemihydrate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
lorcaserin hydrochloride hemihydrate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lorcaserin hydrochloride hemihydrate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
lorcaserin hydrochloride hemihydrate drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
lorcaserin hydrochloride hemihydrate drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
lorcaserin hydrochloride hemihydrate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
lorcaserin hydrochloride hemihydrate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
lorcaserin hydrochloride hemihydrate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eisai Inc | lorcaserin hydrochloride hemihydrate | 62856-529 |
| >Company | >Ingredient | >NDC |
lorcaserin hydrochloride hemihydrate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch